These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Physostigmine stimulates phosphoinositide breakdown in the rat neostriatum. Góngora JL; Sierra A; Mariscal S; Aceves J Eur J Pharmacol; 1988 Oct; 155(1-2):49-55. PubMed ID: 2854073 [TBL] [Abstract][Full Text] [Related]
3. The effects of 4-aminopyridine and tetrodotoxin on the release of acetylcholine from rat striatal slices. Dolezal V; Tucek S Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(2):90-5. PubMed ID: 6888572 [No Abstract] [Full Text] [Related]
4. Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum. Acquas E; Di Chiara G Eur J Pharmacol; 1999 Nov; 383(3):275-9. PubMed ID: 10594319 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and inhibitory properties of some carbamates on carbonic anhydrase and acetylcholine esterase. Yılmaz S; Akbaba Y; Özgeriş B; Köse LP; Göksu S; Gülçin İ; Alwasel SH; Supuran CT J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1484-91. PubMed ID: 26985691 [TBL] [Abstract][Full Text] [Related]
6. New N,N-dimethylcarbamate inhibitors of acetylcholinesterase: design synthesis and biological evaluation. De Vita D; Pandolfi F; Ornano L; Feroci M; Chiarotto I; Sileno I; Pepi F; Costi R; Di Santo R; Scipione L J Enzyme Inhib Med Chem; 2016; 31(sup4):106-113. PubMed ID: 27594053 [TBL] [Abstract][Full Text] [Related]
7. A novel acetylcholinesterase inhibitor, Ro 46-5934, which interacts with muscarinic M2 receptors. Borroni E; Damsma G; Giovacchini C; Mutel V; Jakob-Rötne R; Da Prada M Biochem Soc Trans; 1994 Aug; 22(3):755-8. PubMed ID: 7821679 [No Abstract] [Full Text] [Related]
8. In vitro effects of organophosphorus anticholinesterases on muscarinic receptor-mediated inhibition of acetylcholine release in rat striatum. Liu J; Chakraborti T; Pope C Toxicol Appl Pharmacol; 2002 Jan; 178(2):102-8. PubMed ID: 11814330 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease. Smith CP; Bores GM; Petko W; Li M; Selk DE; Rush DK; Camacho F; Winslow JT; Fishkin R; Cunningham DM; Brooks KM; Roehr J; Hartman HB; Davis L; Vargas HM J Pharmacol Exp Ther; 1997 Feb; 280(2):710-20. PubMed ID: 9023283 [TBL] [Abstract][Full Text] [Related]
11. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats. Xiao WB; Nordberg A; Zhang X J Pharmacol Exp Ther; 1993 May; 265(2):759-64. PubMed ID: 8496822 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors. Horáková E; Drabina P; Brož B; Štěpánková Š; Vorčáková K; Královec K; Havelek R; Sedlák M J Enzyme Inhib Med Chem; 2016; 31(sup3):173-179. PubMed ID: 27476673 [TBL] [Abstract][Full Text] [Related]
13. Cholinesterase studies with (R) (+)- and (S)(-)-5-(1,3,3-trimethylindolinyl)-N-(1-phenylethyl)carbamate. Lieske CN; Gepp RT; Maxwell DM; Clark JH; Broomfield CA; Blumbergs P; Tseng CC J Enzyme Inhib; 1992; 6(4):283-91. PubMed ID: 1284965 [TBL] [Abstract][Full Text] [Related]
14. Dopaminergic regulation of striatal acetylcholine release: the critical role of acetylcholinesterase inhibition. Acquas E; Fibiger HC J Neurochem; 1998 Mar; 70(3):1088-93. PubMed ID: 9489729 [TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase inhibitors block acetylcholine-evoked release of dopamine in rat striatum, in vivo. Dajas-Bailador F; Costa G; Emmett S; Bonilla C; Dajas F Brain Res; 1996 May; 722(1-2):12-8. PubMed ID: 8813345 [TBL] [Abstract][Full Text] [Related]
16. The effect of acetylcholinesterase inhibition on the release of acetylcholine from the striatum in vivo: interaction with autoreceptor responses. de Boer P; Westerink BH; Horn AS Neurosci Lett; 1990 Aug; 116(3):357-60. PubMed ID: 2243615 [TBL] [Abstract][Full Text] [Related]
17. Ortho effects in quantitative structure-activity relationships for acetylcholinesterase inhibition by aryl carbamates. Lin G; Liu YC; Lin YF; Wu YG J Enzyme Inhib Med Chem; 2004 Oct; 19(5):395-401. PubMed ID: 15648653 [TBL] [Abstract][Full Text] [Related]
18. Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles. Samadi A; Marco-Contelles J; Soriano E; Alvarez-Pérez M; Chioua M; Romero A; González-Lafuente L; Gandía L; Roda JM; López MG; Villarroya M; García AG; Ríos Cde L Bioorg Med Chem; 2010 Aug; 18(16):5861-72. PubMed ID: 20656495 [TBL] [Abstract][Full Text] [Related]
19. Carbamate ester prodrugs of dopaminergic compounds: synthesis, stability, and bioconversion. Hansen KT; Faarup P; Bundgaard H J Pharm Sci; 1991 Aug; 80(8):793-8. PubMed ID: 1686464 [TBL] [Abstract][Full Text] [Related]
20. Syntheses and anticholinesterase activity of tetrahydrobenzazepine carbamates. Chen YL; Liston D; Nielsen J; Chapin D; Dunaiskis A; Hedberg K; Ives J; Johnson J; Jones S J Med Chem; 1994 Jun; 37(13):1996-2000. PubMed ID: 8027982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]